Allogenic Bone Marrow Mesenchymal Stem Cells Infusion in Patients With Steroid-refractory GVHD

Key facts

Sponsor

National Institute of Blood and Marrow Transplant (NIBMT), Pakistan

Principal Investigator

Parvez Ahmed, FCPS, MCPS

Armed Forces Bone Marrow Transplant Centre, Rawalpindi, Pakistan

Intervention

Mesenchymal Stem Cells(biological)

Enrollment

10 enrolled

Eligibility

1-65 years · All sexes

Timeline

2015 – 2016

Study locations (1)

• Armed Forces Bone Marrow Transplant Centre, Rawalpindi, Punjab Province, Pakistan

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Rare disorder potentially indicated for transplant or complication after transplantation

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE1NCT04886726
  PTCY Plus uhCG/EGF for Graft Versus Host Disease Prophylaxis
  Henry Ford Health System
• RECRUITINGPHASE2, PHASE3NCT03818334
  Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological Malignancies
  Hospital Israelita Albert Einstein

See all trials for Rare disorder potentially indicated for transplant or complication after transplantation →